These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8496928)

  • 21. K(+)-channel openers protect the myocardium against ischemia-reperfusion injury.
    Popescu LM; Musat S; Trifan OC; Leabu M; Tigaret CM; Popescu M; Popescu A; Hinescu ME; Moraru II; Das DK
    Ann N Y Acad Sci; 1994 Jun; 723():398-400. PubMed ID: 8030895
    [No Abstract]   [Full Text] [Related]  

  • 22. RP 49356 and cromakalim relax airway smooth muscle in vitro by opening a sulphonylurea-sensitive K+ channel: a comparison with nifedipine.
    Raeburn D; Brown TJ
    J Pharmacol Exp Ther; 1991 Feb; 256(2):480-5. PubMed ID: 1899701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-ischaemic actions of potassium channel openers in experimental myocardial ischaemia/reperfusion injury in dogs.
    Auchampach JA; Gross GJ
    Eur Heart J; 1993 Jul; 14 Suppl B():10-5. PubMed ID: 8370365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. KCO912: a potent and selective opener of ATP-dependent potassium (K(ATP)) channels which suppresses airways hyperreactivity at doses devoid of cardiovascular effects.
    Buchheit KH; Manley PW; Quast U; Russ U; Mazzoni L; Fozard JR
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):220-30. PubMed ID: 11882918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding of the K+ channel opener [3H]P1075 in rat isolated aorta: relationship to functional effects of openers and blockers.
    Quast U; Bray KM; Andres H; Manley PW; Baumlin Y; Dosogne J
    Mol Pharmacol; 1993 Mar; 43(3):474-81. PubMed ID: 8450836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.
    Katz LB; Giardino EC; Salata JJ; Moore JB; Falotico R
    J Pharmacol Exp Ther; 1993 Nov; 267(2):648-56. PubMed ID: 8246137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of three K+ channel openers on airways and pulmonary circulation in the isolated guinea-pig lung.
    Dumas M; Dumas JP; Advenier C; Giudicelli JF
    Eur J Pharmacol; 1993 Aug; 239(1-3):141-7. PubMed ID: 8223889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The individual enantiomers of cis-cromakalim possess K+ channel opening activity.
    Quast U; Villhauer EB
    Eur J Pharmacol; 1993 Apr; 245(2):165-71. PubMed ID: 8491256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Highly potent 1,4-benzothiazine derivatives as K(ATP)-channel openers.
    Cecchetti V; Calderone V; Tabarrini O; Sabatini S; Filipponi E; Testai L; Spogli R; Martinotti E; Fravolini A
    J Med Chem; 2003 Aug; 46(17):3670-9. PubMed ID: 12904071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potassium channel openers prevent potassium-induced calcium loading of cardiac cells: possible implications in cardioplegia.
    López JR; Jahangir R; Jahangir A; Shen WK; Terzic A
    J Thorac Cardiovasc Surg; 1996 Sep; 112(3):820-31. PubMed ID: 8800173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular pharmacology of potassium channel openers in vascular smooth muscle.
    Quast U; Guillon JM; Cavero I
    Cardiovasc Res; 1994 Jun; 28(6):805-10. PubMed ID: 7923283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 3-and 4-substituted 4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxides as potassium channel openers: synthesis, pharmacological evaluation, and structure-activity relationships.
    de Tullio P; Pirotte B; Lebrun P; Fontaine J; Dupont L; Antoine MH; Ouedraogo R; Khelili S; Maggetto C; Masereel B; Diouf O; Podona T; Delarge J
    J Med Chem; 1996 Feb; 39(4):937-48. PubMed ID: 8632417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of two K+ channel openers, aprikalim and pinacidil, on hypoxic pulmonary vasoconstriction.
    Dumas JP; Dumas M; Sgro C; Advenier C; Giudicelli JF
    Eur J Pharmacol; 1994 Sep; 263(1-2):17-23. PubMed ID: 7821349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of contractions of the isolated human myometrium by potassium channel openers.
    Cheuk JM; Hollingsworth M; Hughes SJ; Piper IT; Maresh MJ
    Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):953-60. PubMed ID: 8456909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of vasoconstriction by potassium channel opener aprikalim in human conduit arteries used as bypass grafts.
    He GW; Yang CQ
    Br J Clin Pharmacol; 1997 Oct; 44(4):353-9. PubMed ID: 9354310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction of ischemic damage in isolated rat hearts by the potassium channel opener, RP 52891.
    Grover GJ; Dzwonczyk S; Sleph PG
    Eur J Pharmacol; 1990 Nov; 191(1):11-8. PubMed ID: 2128745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and selective coronary vasodilatory activity of 3,4-dihydro-2,2-bis(methoxymethyl)-2H-1-benzopyran-3-ol derivatives: novel potassium channel openers.
    Cho H; Katoh S; Sayama S; Murakami K; Nakanishi H; Kajimoto Y; Ueno H; Kawasaki H; Aisaka K; Uchida I
    J Med Chem; 1996 Sep; 39(19):3797-805. PubMed ID: 8809167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross tolerance between cromakalim and RP49356 in the uterus of the rat in vivo and in vitro.
    Piper I; Downing SJ; Hollingsworth M
    Eur J Pharmacol; 1992 Sep; 219(3):347-53. PubMed ID: 1425963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and SAR of novel potassium channel openers targeted for urge urinary incontinence. 1. N-Cyanoguanidine bioisosteres possessing in vivo bladder selectivity.
    Butera JA; Antane MM; Antane SA; Argentieri TM; Freeden C; Graceffa RF; Hirth BH; Jenkins D; Lennox JR; Matelan E; Norton NW; Quagliato D; Sheldon JH; Spinelli W; Warga D; Wojdan A; Woods M
    J Med Chem; 2000 Mar; 43(6):1187-202. PubMed ID: 10737752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nicorandil: differential contribution of K+ channel opening and guanylate cyclase stimulation to its vasorelaxant effects on various endothelin-1-contracted arterial preparations. Comparison to aprikalim (RP 52891) and nitroglycerin.
    Borg C; Mondot S; Mestre M; Cavero I
    J Pharmacol Exp Ther; 1991 Nov; 259(2):526-34. PubMed ID: 1682478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.